Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00356278 · ClinicalTrials.gov registry record · Phase 2
D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD
A Phase 2 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
- 156
- Enrollment target
NCT00356278 is a Phase 2 study that has completed, run by Emory University. The registered enrollment target is 156 participants.
The verdict
NCT00356278, a Phase 2 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 156 participants
- Enrollment target
Study Summary
This study will determine whether a combination of virtual reality exposure therapy and D-cycloserine will reduce post-traumatic stress disorder symptoms in Iraq war veterans.
Interventions
- DRUG Placebo
- DRUG Alprazolam
- BEHAVIORAL Virtual Reality Exposure Therapy
- DRUG D-Cycloserine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2006-09 |
| Est. Completion | 2014-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00356278
The ClinicalTrials.gov registry entry for NCT00356278 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00356278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00356278 about?
NCT00356278 is a clinical study titled "D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD". This study will determine whether a combination of virtual reality exposure therapy and D-cycloserine will reduce post-traumatic stress disorder symptoms in Iraq war veterans.
What is the current status of trial NCT00356278?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 156 participants. The study started on 2006-09. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00356278?
The interventions under investigation include: Placebo (DRUG), Alprazolam (DRUG), Virtual Reality Exposure Therapy (BEHAVIORAL), D-Cycloserine (DRUG).
Who is sponsoring clinical trial NCT00356278?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.